Here is my expert synthesis:
The single most promising near-term path to field-deployable blight-resistant American chestnut trees is The American Chestnut Foundation's (TACF) pivot to recurrent genomic selection within its hybrid breeding populations. More than a century after two introduced pathogens killed billions of American chestnut trees, introgression of resistance alleles from Chinese chestnuts has contributed to the recovery of self-sustaining populations , but the original Burnham backcross plan stalled because progress has been slow because of the complex genetic architecture of resistance . The landmark February 2026 study published in *Science* by Westbrook et al. now provides a concrete roadmap: by sequencing genomes and comparing genetic patterns with real-world disease outcomes, the team showed that resistance can be predicted using DNA data alone, and "with genome-enabled breeding, we expect the next generation of trees to have twice the average blight resistance of our current population, with an average of 75 percent American chestnut ancestry." This approach effectively supersedes both the conventional backcross pipeline—which yielded trees with only an average of 83% American chestnut ancestry and blight resistance that is intermediate between F₁ hybrids and American chestnut —and the embattled transgenic Darling line as the primary actionable strategy. The transgenic effort, meanwhile, remains in regulatory limbo: in 2023, TACF decided to withdraw support of the D58 transgenic chestnut petitions after observational data indicated inconsistent blight resistance, a negative impact on growth, and decreased survival rates , compounded by a mishap in which any material known as "Darling 58" was actually "Darling 54." Although SUNY-ESF continues to seek deregulation of Darling 54 independently— APHIS concluded that the "Darling 54 American chestnut is unlikely to pose a greater plant pest risk than its nonmodified parent" — it is still undergoing federal regulatory review by the EPA, USDA-APHIS, and FDA, and timing is not predictable for any of the agencies , and TACF's withdrawal of support means the genomic selection breeding strategy is now the primary vehicle for large-scale restoration.
The most significant recent scientific development is the Westbrook et al. (2026) *Science* paper, which assembled reference genomes for both American and Chinese chestnut and applied genome-wide association and genomic prediction methods to thousands of phenotyped hybrid trees. To better understand blight resistance, the team compared reference genomes, gene expression responses, and stem metabolite profiles of the resistant Chinese and susceptible American chestnut species, conducted large-scale phenotyping and genotyping in hybrids, and showed that significant resistance gains are possible through selectively breeding trees with an average of 70 to 85% American chestnut ancestry. This matters for two reasons. First, it confirmed what earlier work had suggested— blight resistance is polygenic —which explains why the Burnham backcross hypothesis of a few major genes proved overly optimistic. Second, the genomic selection framework dramatically compresses cycle times: as Jason Holliday put it, "instead of waiting years to see how a tree performs, we can use its DNA to predict resistance and make better decisions much earlier in the breeding process." The study also integrated multiple lines of evidence to discover candidate alleles for blight resistance and susceptibility, facilitating future gene editing , although the authors note that genome editing to knock out susceptibility alleles or insert multiple resistance alleles from Asian chestnuts will be challenging given the quantitative architecture of blight resistance and the long time frames of 5–10 years to validate candidate alleles in trees. The paper thus repositions the entire restoration effort on a quantitative-genetics footing, replacing the legacy model of simple introgression.
Several major bottlenecks remain. On the institutional side, the transgenic pathway is fractured: in late October 2023, partners at the University of New England and University of Maine informed TACF of a possible mix-up of pollen early in the D58 breeding program, and TACF independently verified that the OxO gene of all trees thought to be Darling 58 was on a different chromosome than expected. This D54/D58 labeling debacle consumed years of field-trial data and institutional trust. TACF now suggests that if work is to start over at those early diversification stages, it makes sense to focus on new OxO lines that express the gene only in tissues infected with blight, as confining OxO expression to blight-infected tissues should reduce the metabolic cost and improve forest competitiveness. Scientifically, the second existential pathogen—*Phytophthora cinnamomi*, which causes root rot—remains inadequately addressed. Chestnut is quite susceptible to this root disease in the southern half of its former range, and the pathogen is expected to move northward as climate warms. Landscape modeling has shown that root rot greatly reduced chestnut biomass on the landscape even when resistance was at the highest levels currently observed, and warming climate enhanced the virulence of the pathogen. Some projections suggest that the root disease could reach throughout the entire current chestnut range by 2080. Breeding simultaneously for resistance to both blight and root rot is essential, but the genetic architecture of *Phytophthora* resistance is even less characterized than that of blight resistance, and genetic resistance to root rot appears to vary among individual chestnut trees, and the prevalence of resistance is highly uncertain. Additionally, as land development and environmental stressors continue to kill resprouting genotypes, the remaining wild population of American chestnuts is a dwindling resource for restoration , creating urgency for germplasm conservation that outpaces current collection efforts.
New funding would have the highest impact-per-dollar in three tightly connected areas. First, and most immediately, expanding the genotyping and phenotyping infrastructure that underpins TACF's new genomic selection program is critical. By pairing large-scale field trials with genome sequencing, the team has created a road map for restoring the species more efficiently and at a much larger scale , but TACF's chapters, with their decades of experience growing chestnuts and many established field sites, are uniquely positioned to manage this network of replicated progeny tests —and those chapters need resources to genotype the thousands of candidate trees now awaiting evaluation. Second, investment in dual-pathogen resistance screening is vital. Some resistance to Phytophthora root rot has been found in families providing blight resistance used in TACF's breeding program, and TACF now plans to cross individuals from those families with transgenic blight-resistant chestnut to combine both resistances , but this work requires sustained field-trial capacity in the southern range where root rot pressure is strongest, as well as controlled inoculation studies. Third, germplasm conservation orchards to bank the adaptive genetic diversity of wild surviving American chestnuts deserve priority. Restoration populations need sufficient genetic diversity to adapt to a wide geographic range and changing climates , yet the wild remnant population is declining continuously. Philanthropic and federal investments in these three areas—genomic selection infrastructure, dual-pathogen phenotyping, and germplasm banking—would yield outsized returns because they address the rate-limiting steps in the pipeline between the laboratory breakthroughs now in hand and the ecologically meaningful-scale plantings that restoration ultimately demands.